Opus Genetics IRD Exercised (in dollars per share)
Exercised (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept ird:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriodExercisePricePerWarrant.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's exercised (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Opus Genetics's exercised (in dollars per share)?
- Opus Genetics (IRD) reported exercised (in dollars per share) of $0.00 in Q1 2026.
- What does exercised (in dollars per share) mean?
- The average price per share at which equity instruments, such as warrants or non-option awards, were exercised during the period. This metric indicates the cash inflow generated from the exercise of these instruments. It serves as a measure of the strike price levels relative to the current market value of the company's stock.